SC 13G/A: IONIS PHARMACEUTICALS INC
Ticker: IONS · Form: SC 13G/A · Filed: Nov 14, 2024 · CIK: 874015
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by IONIS PHARMACEUTICALS INC.
Risk Assessment
Risk Level: low
Filing Stats: 921 words · 4 min read · ~3 pages · Grade level 9.4 · Accepted 2024-11-14 20:34:57
Key Financial Figures
- $0.001 — e of Class of Securities: Common Stock, $0.001 Par Value 2(e) CUSIP Number: 46222210
Filing Documents
- d877529dsc13ga.htm (SC 13G/A) — 47KB
- 0001193125-24-259051.txt ( ) — 49KB
SIGNATURES
SIGNATURES After reasonable inquiry and the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BB Biotech AG Date: November 14, 2024 By: /s/ Martin Gubler Signatory Authority Name: Martin Gubler Title: Signatory Authority Date: November 14, 2024 By: /s/ Ivo Betschart Signatory Authority Name: Ivo Betschart Title: Signatory Authority Biotech Invest N.V. Date: November 14, 2024 By: /s/ Jan Bootsma Signatory Authority Name: Jan Bootsma Title: Signatory Authority Date: November 14, 2024 By: /s/ Hugo van Neutegem Signatory Authority Name: Hugo van Neutegem Title: Signatory Authority 6 of 7 Exhibit Index Exhibit A: Agreement by and between BB Biotech AG and Biotech Invest N.V. with respect to the filing of this disclosure statement.* * Previously filed as an exhibit to BB Biotech AG and Biotech Invest N.V.s Schedule 13G filed with the Securities and Exchange Commission on February 13, 2020. 7 of 7